Epstein-Barr Virus-associated Lymphoproliferative Disorder with Encephalitis Following Anti-thymocyte Globulin for Aplastic Anemia Resolved with Rituximab Therapy: A Case Report and Literature Review-Reference-Cited by-同舟云学术

Epstein-Barr Virus-associated Lymphoproliferative Disorder with Encephalitis Following Anti-thymocyte Globulin for Aplastic Anemia Resolved with Rituximab Therapy: A Case Report and Literature Review

Published:2017 Issue:6 Volume:56 Page:701-706
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Mashima Kiyomi¹,Yano Shingo¹,Yokoyama Hiroki¹,Saito Takeshi¹,Machishima Tomohito¹,Shimada Takaki¹,Yahagi Yuichi¹,Takahara Shinobu¹,Sugiyama Katsuki¹,Ogasawara Yoji¹,Minami Jiro¹,Kamiyama Yutaro¹,Katsube Atsushi¹,Suzuki Kazuhito¹,Ohshima Sayaka¹,Yamada Hisashi²,Usui Noriko³,Aiba Keisuke¹

Affiliation:

1. Department of Oncology and Hematology, The Jikei University School of Medicine, Japan

2. Research Center for Medical Science, Core Research Facilities for Basic Science (Molecular Genetics), The Jikei University School of Medicine, Japan

3. Department of Oncology and Hematology, The Jikei University School of Medicine, Daisan Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/56/6/56_56.7722/_pdf

Reference30 articles.

1. 1. Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 350: 1328-1337, 2004.

2. 2. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Volume 2. 2008.

3. 3. Landgren O, Gilbert ES, Rizzo JD, et al. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood 13: 4992-5001, 2009.

4. 4. Meijer E, Slaper-Cortenbach IC, Thijsen SF, Dekker AW, Verdonck LF. Increased incidence of EBV-associated lymphoproliferative disorders after allogeneic stem cell transplantation from matched unrelated donors due to a change of T cell depletion technique. Bone Marrow Transplant 29: 335-339, 2002.

5. 5. van der Velden WJ, Mori T, Stevens WB, et al. Reduced PTLD-related mortality in patients experiencing EBV infection following allo-SCT after the introduction of a protocol incorporating pre-emptive rituximab. Bone Marrow Transplant 48: 1465-1471, 2013.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epstein-Barr Virus Encephalitis: A Review of Case Reports from the Last 25 Years;Microorganisms;2023-11-21

2. Aplastic Anemia with Epstein-Barr Virus Reactivation after Anti-thymocyte Globulin Therapy;Internal Medicine;2023-09-01

3. Complicaciones neurológicas en pacientes sometidos a trasplante de progenitores hematopoyéticos;Revista de Neurología;2021

4. COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia;Neurology - Neuroimmunology Neuroinflammation;2020-05-26

5. A new therapy in Epstein-Barr virus-associated lymphoproliferative disease: a case report and a revision of the literature;Italian Journal of Pediatrics;2019-11-04